Cheng-Wei Cheng

Cheng-Wei Cheng

Auto-generated profile, based on publicly available information

Cheng-Wei Cheng

Institute of Information Science, Academia Sinica, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JJJia-Tsrong Jan
Jia-Tsrong Jan
TCTing-Jen Rachel Cheng
Ting-Jen Rachel Cheng
YJYu-Pu Juang
Yu-Pu Juang
HMHsiu-Hua Ma
Hsiu-Hua Ma
YWYing-Ta Wu
Ying-Ta Wu
CWChi-Huey Wong
Chi-Huey Wong
Significance: COVID-19 is a global pandemic currently lacking an effective cure. We used a cell-based infection assay to screen more than 3,000 agents used in humans and animals and identified 15 with antiinfective activity, ranging from 0.1 nM to 50 μM. We then used in vitro enzymatic assays combined with computer modeling to confirm the activity of those against the viral protease and RNA polymerase. In addition, several herbal medicines were found active in the cell-based infection assay. To further evaluate the efficacy of these promising compounds in animal models, we developed a challenge assay with hamsters and found that mefloquine, nelfinavir, and extracts of Ganoderma lucidum (RF3), Perilla frutescens , and Mentha haplocalyx were effective against SARS-CoV-2 infection.

6 April 2022 in Science Translational Medicine
Verified
Journal Article
Open access
HHHan-Yi Huang
Han-Yi Huang
HLHsin-Yu Liao
Hsin-Yu Liao
XCXiaorui Chen
Xiaorui Chen
SWSzu-Wen Wang
Szu-Wen Wang
CCCheng-Wei Cheng
Cheng-Wei Cheng
CWChi-Huey Wong
Chi-Huey Wong
A major challenge to end the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to develop a broadly protective vaccine that elicits long-term immunity. As the key immunogen, the viral surface spike (S) protein is frequently mutated, and conserved epitopes are shielded by glycans. Here, we revealed that S protein glycosylation has site-differential effects on viral infectivity. We found that S protein generated by lung epithelial cells has glycoforms associated with increased infectivity. Compared to the fully glycosylated S protein, immunization of S protein with N-glycans trimmed to the mono-GlcNAc–decorated state (S MG ) elicited stronger immune responses and better protection for human angiotensin-converting enzyme 2 (hACE2) transgenic mice against variants of concern (VOCs). In addition, a broadly neutralizing monoclonal antibody was identified from S MG -immunized mice that could neutralize wild-type SARS-CoV-2 and VOCs with subpicomolar potency. Together, these results demonstrate that removal of glycan shields to better expose the conserved sequences has the potential to be an effective and simple approach for developing a broadly protective SARS-CoV-2 vaccine.

12 December 2008 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
CCCheng-Wei Cheng
Cheng-Wei Cheng
ESEmily Chia-Yu Su
Emily Chia-Yu Su
JHJenn-Kang Hwang
Jenn-Kang Hwang
TSTing-Yi Sung
Ting-Yi Sung
WHWen-Lian Hsu
Wen-Lian Hsu
Background: RNA-protein interaction plays an essential role in several biological processes, such as protein synthesis, gene expression, posttranscriptional regulation and viral infectivity. Identification of RNA-binding sites in proteins provides valuable insights for biologists. However, experimental determination of RNA-protein interaction remains time-consuming and labor-intensive. Thus, computational approaches for prediction of RNA-binding sites in proteins have become highly desirable. Extensive studies of RNA-binding site prediction have led to the development of several methods. However, they could yield low sensitivities in trade-off for high specificities. Results: We propose a method, RNAProB, which incorporates a new smoothed position-specific scoring matrix (PSSM) encoding scheme with a support vector machine model to predict RNA-binding sites in proteins. Besides the incorporation of evolutionary information from standard PSSM profiles, the proposed smoothed PSSM encoding scheme also considers the correlation and dependency from the neighboring residues for each amino acid in a protein. Experimental results show that smoothed PSSM encoding significantly enhances the prediction performance, especially for sensitivity. Using five-fold cross-validation, our method performs better than the state-of-the-art systems by 4.90%~6.83%, 0.88%~5.33%, and 0.10~0.23 in terms of overall accuracy, specificity, and Matthew's correlation coefficient, respectively. Most notably, compared to other approaches, RNAProB significantly improves sensitivity by 7.0%~26.9% over the benchmark data sets. To prevent data over fitting, a three-way data split procedure is incorporated to estimate the prediction performance. Moreover, physicochemical properties and amino acid preferences of RNA-binding proteins are examined and analyzed. Conclusion: Our results demonstrate that smoothed PSSM encoding scheme significantly enhances the performance of RNA-binding site prediction in proteins. This also supports our assumption that smoothed PSSM encoding can better resolve the ambiguity of discriminating between interacting and non-interacting residues by modelling the dependency from surrounding residues. The proposed method can be used in other research areas, such as DNA-binding site prediction, protein-protein interaction, and prediction of posttranslational modification sites.

6 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
CCCheng-Wei Cheng
Cheng-Wei Cheng
YZYixuan Zhou
Yixuan Zhou
WPWen-Harn Pan
Wen-Harn Pan
SDSupriya Dey
Supriya Dey
CWChung-Yi Wu
Chung-Yi Wu
CWChi-Huey Wong
Chi-Huey Wong
The programmable one-pot oligosaccharide synthesis method was designed to enable the rapid synthesis of a large number of oligosaccharides, using the software Optimer to search Building BLocks (BBLs) with defined relative reactivity values (RRVs) to be used sequentially in the one-pot reaction. However, there were only about 50 BBLs with measured RRVs in the original library and the method could only synthesize small oligosaccharides due to the RRV ordering requirement. Here, we increase the library to include 154 validated BBLs and more than 50,000 virtual BBLs with predicted RRVs by machine learning. We also develop the software Auto-CHO to accommodate more data handling and support hierarchical one-pot synthesis using fragments as BBLs generated by the one-pot synthesis. This advanced programmable one-pot method provides potential synthetic solutions for complex glycans with four successful examples demonstrated in this work.

16 January 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
KLKe-Shiuan Lynn
Ke-Shiuan Lynn
CCChen-Chun Chen
Chen-Chun Chen
TLT. Mamie Lih
T. Mamie Lih
CCCheng-Wei Cheng
Cheng-Wei Cheng
WSWan-Chih Su
Wan-Chih Su
TSTing-Yi Sung
Ting-Yi Sung

21 January 2013 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
SLScott Yi-Heng Lin
Scott Yi-Heng Lin
CCCheng-Wei Cheng
Cheng-Wei Cheng
Emily Chia-Yu SuEmily Chia-Yu Su
Emily Chia-Yu Su
Background: Development of computational tools that can accurately predict presence and location of B-cell epitopes on pathogenic proteins has a valuable application to the field of vaccinology. Because of the highly variable yet enigmatic nature of B-cell epitopes, their prediction presents a great challenge to computational immunologists. Methods: We propose a method, BEEPro (B-cell e pitope prediction by e volutionary information and pro pensity scales), which adapts a linear averaging scheme on 16 properties using a support vector machine model to predict both linear and conformational B-cell epitopes. These 16 properties include position specific scoring matrix (PSSM), an amino acid ratio scale, and a set of 14 physicochemical scales obtained via a feature selection process. Finally, a three-way data split procedure is used during the validation process to prevent over-estimation of prediction performance and avoid bias in our experiment results. Results: In our experiment, first we use a non-redundant linear B-cell epitope dataset curated by Sollner et al. for feature selection and parameter optimization. Evaluated by a three-way data split procedure, BEEPro achieves significant improvement with the area under the receiver operating curve (AUC) = 0.9987, accuracy = 99.29%, mathew's correlation coefficient (MCC) = 0.9281, sensitivity = 0.9604, specificity = 0.9946, positive predictive value (PPV) = 0.9042 for the Sollner dataset. In addition, the same parameters are used to evaluate performance on other independent linear B-cell epitope test datasets, BEEPro attains an AUC which ranges from 0.9874 to 0.9950 and an accuracy which ranges from 93.73% to 97.31%. Moreover, five-fold cross-validation on one benchmark conformational B-cell epitope dataset yields an accuracy of 92.14% and AUC of 0.9066. Conclusions: Compared with other current models, our method achieves a significant improvement with respect to AUC, accuracy, MCC, sensitivity, specificity, and PPV. Thus, we have shown that an appropriate combination of evolutionary information and propensity scales with a support vector machine model can significantly enhance the prediction performance of both linear and conformational B-cell epitopes.